查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球胆道支架市场-2022-2029
市场调查报告书
商品编码
1140757

全球胆道支架市场-2022-2029

Global Biliary Stents Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计胆道支架的市场规模在预测期内（2022-2029 年）将以 4.4% 的复合年增长率增长。

胆道支架是一种没有涂层或覆盖物的小网状管。胆道支架用于治疗胆管中存在的阻塞。支架通常插入肝臟以治疗肝阻塞和阻塞性肝病，例如胆囊炎、黄疸、肝胆疾病和胆管炎。

市场动态

主要驱动因素是胆道疾病患病率的增加、对微创技术的需求增加、技术进步、老年人口的增长、公众意识的提高以及对生物可吸收支架的需求增加。

新兴市场的发展正在推动市场增长。

胆道支架的不断进步和开发正在推动全球胆道支架市场的增长。例如，胆道支架技术自问世以来已经走过了漫长的道路。在使用的材料以及设计和部署策略方面取得了重大进展。选择范围已从塑料和金属支架扩展到更广泛的材料和製造技术，为临床医生提供了多种选择，包括自膨胀金属支架和生物可吸收支架。生物可吸收胆管支架仍处于临床应用的早期阶段。此外，正在发生的市场发展正在推动全球市场的增长。例如，21 年 7 月 9 日，QualiMed 的 UNITY-B 经皮球囊可扩张生物降解胆道支架 (BEBS) 获得了 CE 标誌批准，这是一种用于胆道应用的专用经皮可生物降解金属合金支架植入物。

术后并发症正在减缓胆道支架市场的增长。

但是，预计政府对术后并发症和批准的严格规定将抑制市场增长。与胆道支架相关的术后并发症可能会阻碍市场。例如，根据欧洲胃肠病学内窥镜学会的说法，并发症包括胆道感染、胰腺炎、出血、穿孔、支架过早移位和肾功能衰竭。

行业分析。

胆道支架市场报告根据波特五力、研发、流行病学、监管、价格分析等各种行业因素对市场进行了深入分析。

细分分析

金属胆管支架预计将在预测期内（2022-2029 年）主导市场。

金属胆道支架将在 2021 年主导全球市场，由于金属支架在胆道疾病治疗中的使用越来越多，预计在预测期内（2022-2029 年）将出现显着增长。与塑料支架相比，金属支架可以提供更长的支架通畅性。金属支架的可扩展性基于其可扩展性，这反过来可能由于更好的好处而导致更好的客户采用。金属胆管支架技术创新的兴起将在预测期内推动金属胆管支架市场的增长。例如，根据 NIH 的说法，如果患者的预期寿命超过四到六个月，金属支架比塑料胆管支架更具成本效益。因此，在治疗恶性胆道梗阻时，通常首选裸金属支架而不是塑料支架。

区域分析

预计北美将占据大部分市场份额。

北美胰腺疾病患病率的上升正在推动北美地区在预测期内（2022-2029 年）占据市场主导地位。例如，根据美国国立卫生研究院的数据，美国每 10 万人中约有 42 至 73 人患有慢性胰腺炎。它被认为是与胰腺功能不全相关的最常见的胰腺疾病。此外，根据美国癌症协会的数据，约有 62,210 人（32,970 名男性和 29,240 名女性）将被诊断出患有胰腺癌，约有 49,830 人（25,970 名男性和 23,860 名女性）死于胰腺癌。此外，北美拥有最先进、最强大的医疗保健基础设施和出色的医疗报销政策，使北美在全球胆管支架市场占据主导地位。

竞争格局

全球胆道支架市场的主要参与者有Boston Scientific Corporation、Brainlab、Q3 Medical Devices Limited、Medtronic、Abbott、Allium Medical Solutions、Aohua Endoscopy Co, Ltd、Changzhou Health Microport Medical Devices、 W. L. Gore &Associates、Inc.，和Cook Medical。主要参与者采取了各种策略，如产品发布、併购、合作伙伴和联盟，为全球胆管支架市场的增长做出贡献。例如，2022 年 8 月 30 日，Medtronic收购了 Affera。

Medtronic

概览

Medtronic PLC 是一家总部位于爱尔兰的美国医疗设备製造商。美敦力公司成立于 1949 年，总部位于美国明尼苏达州明尼阿波利斯市。美敦力经营四项业务：微创治疗组、糖尿病组、恢復性治疗组和心血管组。

产品组合

美敦力提供一系列胆道支架，包括 EverFlex、Protege 和 Visi-Pro。

这份研究报告将提供对大约 40 多个市场数据表、45 多个图表和 200 页（大约）的访问。

内容

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 调查与研发
      • 市场策略
    • 抑制因素
      • 术后并发症
      • 严格监管
    • 商机
    • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 流行病学分析
  • 研发
  • 管道分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按应用程序

  • 胆石症
  • 胆漏
  • 肿瘤
  • 其他

第 8 章按类型

  • 金属支架
  • 塑料支架

第 9 章最终用户

  • 医院
  • 门诊手术中心
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 产品基准

第 12 章公司简介

  • Medtronic
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Boston Scientific Corporation
  • Brainlab
  • Q3 Medical Devices Limited
  • Abbott
  • Allium Medical Solutions
  • Aohua Endoscopy Co., Ltd
  • Changzhou Health Microport Medical Devices
  • W. L. Gore & Associates, Inc.
  • Cook Medical

第 13 章 DataM

简介目录
Product Code: DMMD2180

Market Overview

Biliary Stents Market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.4% during the forecast period (2022-2029).

Biliary stents are small mesh-like tubes with no coating or covering. Biliary stents are used to treat obstructions present in the bile duct. Stents are usually inserted into the liver to treat hepatic blockage and obstructive hepatic diseases, like cholecystitis, jaundice, hepato-biliary diseases, and cholangitis.

Market Dynamics

The major driving forces are the increasing prevalence of biliary diseases, increase in demand for minimally invasive techniques, technological advancements, the rise in geriatric populations, an increase in awareness among the population and rising demand for bioresorbable stents.

The advancements and developments are pushing the market's growth.

The rising advancements and developments in biliary stents drive the global biliary stent market growth. For instance, biliary stent technology has come a long way since its inception. There have been significant advancements in the materials used and design and deployment strategies. Options have expanded from plastic and metallic stents to a wider variety of materials and manufacturing technologies to offer several options to clinicians, including self-expandable metallic stents and bioresorbable stents. Bioresorbable biliary stents are still in the early stages of clinical adoption. Furthermore, the market developments happening are fueling the global market growth. For instance, on 09.07.21, QualiMed received CE mark approval for a dedicated percutaneous biodegradable metal alloy-based stent implant for biliary applications, the UNITY-B Percutaneous Balloon Expandable Biodegradable Biliary Stent (BEBS).

The postoperative complications are slowing the biliary stents market growth.

However, postoperative complications and stringent government regulations for approval are expected to restrain the market growth. The postoperative complications related to biliary stents are likely to hamper the market. For instance, according to the European Society of Gastrointestinal endoscopy, some complications include biliary infection, pancreatitis, bleeding, perforation, early stent migration, and renal failure.

Industry Analysis.

The Biliary Stents market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, research and developments, epidemiology, regulatory, pricing analysis, Etc.

Segment Analysis

The metal biliary stents are estimated to oppress the market during the forecast period (2022-2029).

Metal biliary stents dominated the global market in 2021 and are expected to have significant growth over the forecast period (2022-2029), owing to the increasing use of metal stents for treating biliary diseases. Metal stent gives longer stent patency as compared to plastic stents. Metal stents are available based on their expansion capacity, which may further lead to better customer adoption due to better benefits. The growing innovations in metal biliary stents will drive the metal biliary stents market growth in the forecast period. For instance, according to NIH, Metal stents are more cost-effective than plastic biliary stents if the patient's remaining life expectancy is longer than 4-6 months. Therefore, uncovered metal stents are generally preferred over plastic ones for managing malignant biliary obstruction.

Geographical Analysis

North America is predicted to hold most of the market share.

The growing prevalence of pancreatic diseases in North America pushes the North American region to command the market during the forecast period (2022-2029). For instance, according to the National Institute of Health, chronic pancreatitis occurs in about 42 to 73 per 100,000 of the population in the United States. It is considered the most common pancreatic disorder associated with pancreatic insufficiency. Moreover, according to the American Cancer Society, about 62,210 people (32,970 men and 29,240 women) will be diagnosed with pancreatic cancer, and about 49,830 people (25,970 men and 23,860 women) will die of pancreatic cancer. In addition, North America has the most advanced and robust healthcare infrastructure and better healthcare cost reimbursement policies, contributing to the dominance of North America over the global biliary stents market.

Competitive Landscape

The major global biliary stents market players are Boston Scientific Corporation, Brainlab, Q3 Medical Devices Limited, Medtronic, Abbott, Allium Medical Solutions, Aohua Endoscopy Co., Ltd, Changzhou Health Microport Medical Devices, W. L. Gore & Associates, Inc., and Cook Medical. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the biliary stents market globally. For instance, on AUG 30, 2022, Medtronic acquired Affera.

Medtronic, Plc

Overview

Medtronic plc is Ireland based American medical device company. Medtronic was founded in 1949 and is headquartered in Minneapolis, Minnesota, United States. Medtronics deals with four different businesses: the Minimally Invasive Therapies Group, the Diabetes Group, the Restorative Therapies Group, and the Cardiac and Vascular Group.

Product Portfolio

Medtronic plc `s product portfolio for Biliary Stents has EverFlex, Protege, Visi-Pro etc.

The biliary stents market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Research and Development
      • 4.1.1.2. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Postoperative Complications
      • 4.1.2.2. Stringent Regulatory Bodies
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiological Analysis
  • 5.3. Research and Developments
  • 5.4. Pipeline Analysis
  • 5.5. Supply Chain Analysis
  • 5.6. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Gall Stones
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Biliary Leaks
  • 7.4. Tumor
  • 7.5. Others

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels Segment.
    • 8.1.2. Market Attractiveness Index, By Distribution Channels Segment
  • 8.2. Metal Stents
    • 8.3.1. Introduction
    • 8.3.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.4. Plastic Stents

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 9.1.2. Market Attractiveness Index, By End-User Segment
  • 9.2. Hospitals
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgical Centers
  • 9.4. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Medtronic
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Boston Scientific Corporation
  • 12.3. Brainlab
  • 12.4. Q3 Medical Devices Limited
  • 12.5. Abbott
  • 12.6. Allium Medical Solutions
  • 12.7. Aohua Endoscopy Co., Ltd
  • 12.8. Changzhou Health Microport Medical Devices
  • 12.9. W. L. Gore & Associates, Inc.
  • 12.10. Cook Medical

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact